UNSPSC 85893631: Low dose rate (ldr) brachytherapy of urethra using palladium 103 (pd-103)

This classification denotes the group of activities that yields a radiation therapy intervention or procedure of low dose rate (ldr) brachytherapy of urethra using palladium 103 (pd-103). This intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code DT13BBZ

UNSPSC 85893631 Low dose rate brachytherapy of urethra using palladium 103 is a Commodity code that nominally describes a specialized radiation-oncology procedure, but the single recent state or local opportunity on record—a July 2026 solicitation from the County of Santa Clara Health System—shows a mismatch between the code's medical-procedure scope and actual procurement activity. The Santa Clara RFQ (RFSQHHSFY270052, due October 7, 2026) establishes a qualified vendor pool for temporary health professional staffing across thirteen ancillary clinical categories including audiology, diagnostic imaging, gastroenterology, respiratory care, sterile processing, surgical services, and therapy, explicitly excluding nursing and physician staffing. This is a multiple-award, non-exclusive qualification vehicle with no guaranteed contract volume and a five-year maintenance period. The code shows little relevant recent activity aligned with its nominal scope of brachytherapy services; the single visible opportunity concerns temporary clinical-staff placement rather than oncology procedures or radiation-therapy delivery.

The geographic reach is limited to California, where Santa Clara County Health System is the sole issuing body in the available record. No other state or local procurement offices are visible under this code in the recent-opportunities window. The Santa Clara solicitation accepts proposals for single or multiple specialty categories independently evaluated, with qualifications and scope negotiated case-by-case upon selection to the Qualified List. All responses require electronic submission. This code does not support a sustained business-development focus on state and local brachytherapy procurement; bidders should verify whether recent opportunities have been filed under a more precise oncology or radiation-therapy code before committing resources.